Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xeris Pharmaceuticals Inc

4.82
+0.26005.70%
Post-market: 4.80-0.0200-0.41%19:47 EDT
Volume:6.61M
Turnover:31.47M
Market Cap:741.99M
PE:-12.90
High:4.90
Open:4.59
Low:4.50
Close:4.56
Loading ...

BRIEF-Xeris Biopharma Q4 Net Income USD -5.113 Million

Reuters
·
06 Mar

Xeris Biopharma Holdings Inc FY2024 REV View $201.1 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
06 Mar

Xeris Biopharma Q4 Product Revenue USD 57 Million VS. Ibes Estimate USD 58.1 Million

THOMSON REUTERS
·
06 Mar

Xeris Biopharma Holdings Inc Outlook 2025 Total Revenue Guidance of $255M-$275M

THOMSON REUTERS
·
06 Mar

Xeris Biopharma Q4 Basic EPS USD -0.03

THOMSON REUTERS
·
06 Mar

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Business Wire
·
06 Mar

Xeris Biopharma Holdings Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
04 Mar

Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
27 Feb

Press Release: Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

Dow Jones
·
27 Feb

Xeris Biopharma (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks
·
26 Feb

Xeris Biopharma CEO Ken Johnson to retire, Anh Nguyen to succeed

TIPRANKS
·
24 Feb

Xeris Appoints Anh Nguyen, Md, MBA as Chief Medical Officer

THOMSON REUTERS
·
24 Feb

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Business Wire
·
24 Feb

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 50% stake, while 45% is held by institutions

Simply Wall St.
·
19 Feb

Prem Watsa's Strategic Moves: CVS Health Corp Takes Center Stage with 7.82% Portfolio Share

GuruFocus.com
·
14 Feb

Xeris to Participate in Upcoming Investor Conferences

Business Wire
·
05 Feb